摘要
目的探讨支气管动脉化疗栓塞治疗肺癌的分子学机制及相关临床疗效研究。方法利用自身对比分析法。对我院在2010年1月至2011年1月期间收治的60例肺癌患者,实施支气管动脉化疗栓塞术,并通过术后随访,分析其疗效。结果 60例实行支气管动脉化疗栓塞术治疗的患者,9例患者治疗结果为完全有效占15%,36例患者部分有效占60%,9例患者有好转占15%,6例病情有恶化占10%,所有患者的总有效率为75%。结论临床上利用支气管动脉化疗栓塞治疗术治疗肺癌具有创口小,效果好,安全性高等优点,值得临床上广泛推广使用。
ObjectiveTo investigate the bronchial artery embolization treatment of lung cancer molecular mechanism and clinical efficacy studies. MethodsComparative analysis itself. Our hospital in January 2010 to January 2011 period treated 60 patients with lung cancer, the implementation of bronchial arterial chemoembolization, and through the postoperative follow-up, analysis of its efifcacy.Results60 cases of implementation of bronchial artery chemoembolization patients, 9 patients was completely effective treatment outcomes, 15% partial response in 36 patients accounted for 60%, 9 patients had improved, 15%, 6 cases of the condition has deteriorated account 10% of all patients, the total effective rate was 75%.ConclusionsThe clinical use of bronchial arterial chemoembolization therapy for lung cancer has a small wound, effective, safe, and so on, worthy of clinical widely used.
出处
《中国医药指南》
2014年第20期17-17,19,共2页
Guide of China Medicine
关键词
支气管动脉栓塞
化疗
分子学
肺癌
Bronchial artery embolization
Chemotherapy
Molecular
Lung cancer